Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Shapiro

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cytometry|July 13, 2002
Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorerGeorge Janossy, Ilesh V Jani, Melvyn Kahan, et al.
Photochemistry and Photobiology|August 27, 2002
Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapyQun Chen, Zheng Huang, Hua Chen, et al.
Ophthalmology|April 29, 2014
Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edemaPeter A Campochiaro, Charles C Wykoff, Howard Shapiro, et al.
JAMA Ophthalmology|March 25, 2016
Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular DegenerationGlenn L Stoller, Gregg T Kokame, Richard F Dreyer, et al.
Retina (Philadelphia, Pa.)|October 7, 2010
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor studySrinivas R Sadda, Glenn Stoller, David S Boyer, et al.
Photochemistry and Photobiology|December 5, 2003
Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapyZheng Huang, Qun Chen, Abdus Shakil, et al.
American Journal of Ophthalmology|April 10, 2010
Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trialsIrene A Barbazetto, Namrata Saroj, Howard Shapiro, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 31, 2002
Seniors' preferences for cancer screening and medication use based on absolute risk reductionDonald J Murphy, Gregory J Gahm, Sara Santilli, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 23, 2023
Rabies in an imported dog, Ontario, Canada, 2022Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cytometry|July 13, 2002
Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorerGeorge Janossy, Ilesh V Jani, Melvyn Kahan, et al.
Photochemistry and Photobiology|August 27, 2002
Improvement of tumor response by manipulation of tumor oxygenation during photodynamic therapyQun Chen, Zheng Huang, Hua Chen, et al.
Ophthalmology|April 29, 2014
Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edemaPeter A Campochiaro, Charles C Wykoff, Howard Shapiro, et al.
JAMA Ophthalmology|March 25, 2016
Patterns of Early and Delayed Visual Response to Ranibizumab Treatment for Neovascular Age-Related Macular DegenerationGlenn L Stoller, Gregg T Kokame, Richard F Dreyer, et al.
Retina (Philadelphia, Pa.)|October 7, 2010
Anatomical benefit from ranibizumab treatment of predominantly classic neovascular age-related macular degeneration in the 2-year anchor studySrinivas R Sadda, Glenn Stoller, David S Boyer, et al.
Photochemistry and Photobiology|December 5, 2003
Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapyZheng Huang, Qun Chen, Abdus Shakil, et al.
American Journal of Ophthalmology|April 10, 2010
Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR trialsIrene A Barbazetto, Namrata Saroj, Howard Shapiro, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 31, 2002
Seniors' preferences for cancer screening and medication use based on absolute risk reductionDonald J Murphy, Gregory J Gahm, Sara Santilli, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 23, 2023
Rabies in an imported dog, Ontario, Canada, 2022Paul Di Salvo, Maureen Anderson, Christine Fehlner-Gardiner, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Pageof 5